Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6544.5000 -84.00 (-1.27%)
NSE Jun 06, 2025 15:31 PM
Volume: 361.1K
 

6544.50
-1.27%
ICICI Securities Limited
The USFDA has communicated to Divi's Laboratories its intention to lift the import alert '99-32'' imposed on unit-II (that includes EOU, SEZ and DSN SEZ) of the Vizag API plant. USFDA had inspected this plant between November 29 and December 6, 2016 and issued a Form 483 to the unit with five observations. Subsequently, an import alert was issued to the products manufactured at unit-II under clauses 66-40 and 99-32, with an exemption for 12 products (10 products initially exempted and then two added later on), followed by a warning letter to the plant in May 2017....
Divi's Laboratories Ltd. has gained 44.66% in the last 1 Year
More from Divi's Laboratories Ltd.
Recommended